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ABSTRACT Human mitochondrial ribosomal protein MRPS18-2 (S18-2) is encoded by a cellular gene that is 
located on the human chromosome 6p21.3. We discovered that overexpression of the S18-2 protein led to im-
mortalization and de-differentiation of primary rat embryonic fibroblasts. Cells showed anchorage-independent 
growth pattern. Moreover, pathways characteristic for rapidly proliferating cells were upregulated then. It is 
possible that the S18-2 overexpression induced disturbance in cell cycle regulation. We found that overexpres-
sion of S18-2 protein in human cancer cell lines led to an appearance of multinucleated cells in the selected 
clones. 
KEY WORDS Mitochondrial ribosomal protein S18-2 (MRPS18-2), multinucleated cells, cancer cell line, cell cycle, 
RB binding protein.
INTRODUCTION
Mitochondrial ribosomal protein S18-2 (MrPS18-2, 
nP_05476, S18-2 in the text) is encoded by a cellu-
lar gene located on human chromosome 6p21.3. S18-2 
cDnA was cloned after an analysis of the differentially 
expressed genes in cD34+ hematopoietic progenitor 
cells [1]. the human genome  contains three different 
S18 genes, in contrast to two in C. elegans and one in 
bacteria [2, 3]. the proteins of the S18 family are lo-
calized on the surface of the small subunit (28S) of the 
mammalian mitochondrial ribosome [3]. the function of 
these proteins is largely unknown. 
recently we shown that overexpression of the hu-
man mitochondrial ribosomal protein S18-2 led to im-
mortalization of primary rat embryonic fibroblasts, 
reFs [4]. cells of the derived cell line named 18IM lost 
contact inhibition. Moreover, they acquired the ability 
for anchorage-independent growth in soft agar with a 
high cloning efficiency (more than 90%). Immortalized 
18IM cells expressed the embryonic stem cell mark-
ers SSeA-1, Sox2, and Oct4 that were not detected 
in the original reFs. noteworthy, the 18IM cells lost 
the expression of mesodermal markers like vimen-
tin and smooth-muscle actin. Part of them expressed 
ecto- and endoderm-specific pan-keratin, ectoderm-
specific beta-III-tubulin, and mesoderm-specific 
MHc class II markers; some of the cells differenti-
ated into fat cells in confluent cultures. the 18IM cells 
produced excessive amounts of pyruvate, suggesting 
an enhanced AtP synthesis. Moreover, as was shown 
by microarray analysis and Q-Pcr, many genes en-
coding enzymes that are involved in redox reactions, 
such as AtP synthases, mitogen activated kinases, 
and nADH dehydrogenases, are greatly upregulated 
in the immortalized cells [5]. Pathways of oxidative 
phosphorylation, ubiquinone biosynthesis, PI3K/AKt 
signaling, and fatty acid elongation in mitochondria, 
characteristic for rapidly proliferating cells, were also 
upregulated in the 18IM cells.
earlier we had found that S18-2 specifically binds 
to the retinoblastoma protein, rB [6]. S18-2 competes 
with e2F1 for the rB binding, thus S18-2 might play a 
role in the control of G1-S phase transition [7]. 
In the present work we show that overexpression of 
S18-2 in the human tumor cell lines McF7 and Krc/Y 
leads to the appearance of multinucleated cells.




cloning of S18-2 cDnA into the peGFPc-1 and pc-
MV-tag3A (c-myc-tagged) vectors was described ear-
lier [7]. S18-2 cDnA was also cloned in the peGFPc-1 
vector, coding for a fusion protein GFP-∆LAnA-S18-2, 
with the first 35 amino acids of LAnA, encoded by the 
human herpes virus 8 (HHV8, Kaposi sarcoma asso-
ciated herpes virus) at the 5' end. the sequence was 
verified by direct sequencing, using commercial for-
ward and reverse primers (Stratagene, Santa clara, 
cA, uSA) and Applied Biosystems sequencer (Perkin 
elmer, Wellesley, MA, uSA).
Antibodies
the following primary antibodies were used: mouse 
monoclonal anti-c-myc (clone 9e10, Zymed Laborato-
ries Inc., San Francisco, cA, uSA), anti-Brdu (Becton 
Dickinson (BD), San Jose, cA, uSA), and anti-actin 
(Sigma-Aldrich, St. Louis, MO, uSA); rabbit anti-S18-2 
serum (described in [7]) and anti-MrPS18B (Protein-
tech Group inc, chicago, IL, uSA), and FItc-conju-
gated swine anti-rabbit and rabbit anti-mouse (Dako, 
Glostrup, Denmark). 
Cells, cell culture, immunostaining and imaging
McF7 breast carcinoma and Krc/Y renal carcinoma 
cell lines were cultured at 37°c in a Iscove´s medium 
that contained 10% fetal bovine serum and appropri-
ate antibiotics (penicillin (100 µu/ml) and streptomy-
cin (100 µg/ml)). Periodic staining with Hoechst 33258 
(Sigma-Aldrich) monitored the absence of mycoplasma. 
Prior to transfection experiments, the cells were grown 
on coverslips. the McF7 cells were transfected with 
GFP- and c-myc-tagged constructs (GFP-S18-2 and 
Mt-S18-2, correspondingly), and the Krc/Y cells were 
transfected with GFP-∆LAnA-S18-2 construct, in par-
allel with empty vectors, using Lipofectamine and Plus 
reagent (Life technology, carlsbad, cA), according to 
the manufacturer’s protocol. Immunostaining and dig-
ital image capturing was performed as described else-
where.  Briefly, cells on coverslips were fixed in a 1 : 1 
mixture of cold methanol and acetone (–20°c). After re-
hydration in phosphate-buffered saline (PBS), the cells 
were stained with antibodies. Hoechst 33258 was added 
at a concentration of 0.4 µg/ml for DnA staining. Imag-
es were captured using DAS microscope Leitz DM rB 
with a Hamamatsu dual mode cooled charge-coupled 
device (ccD) camera (c4880; Hamamatsu, Japan). 
Cell cycle analysis by flow cytometry.
One million of living cells were labeled with bromodeox-
yuridine (Brdu, 30 µM) for 30 min at 37°c, trypsinized, 
collected, and fixed in ethanol (75% in PBS) at 4°c for 
at least 10 hours. After this, the cells were treated with 
pepsin (1 mg/ml in 30 mM Hcl) for 30 min at 37°c and 
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anti-Brdu and FItc-conjugated rabbit anti-mouse an-
tibodies and stained with propidium iodide (25 µg/ml 
in PBS). Сells (1 × 104) were analyzed by flow cytom-
etry, using a FAcScan flow cytometer (BD), and the 
percentage of cells in each phase of the cell cycle was 
determined with the help of cellQuest software (BD).
RESULTS AND DISCUSSION
Establishment of MCF7 and KRC/Y sub-
lines, expressing S18-2 constitutively
cells were grown in 6-well-plates prior transfection. 5 
µg of Mt-S18-2 or GFP-∆LAnA-S18-2 plasmid was 
used for transfection. Mt-S18-2 and GFP-S18-2 sig-
nal was observed in the cytoplasm of the transfected 
McF7 cells (Fig. 1, the top row, panels a and c). ear-
lier we have shown that GFP-S18-2 could be targeted 
to the nucleus upon cell transformation [4]. In order to 
achieve a nuclear localization of S18-2, its cDnA was 
cloned in the GFP-∆LAnA fusion vector that contained 
the first 35 amino acids of LAnA, the HHV8-encoded 
latent nuclear antigen. It was shown that n-terminus 
of LAnA binds to histones H2A and H2B to tether a 
HHV8 episome to a chromosome [8]. Despite that, the 
GFP-∆LAnA-S18-2 fusion protein was observed main-
ly in the cytoplasm of Krc/Y cells (Fig. 1, the lower 
row, panels d and f). 48 hours after transfection the 
cells were transferred to a Petri dish (7.5 cm in diam-
eter) and the selective medium that contained 2 mg/ml 
G418 was applied. three weeks later, some of the clones 
that had survived (12 clones for Mt-S18-2 and GFP-
∆LAnA-S18-2 plasmids) were isolated and analyzed by 
Western blotting and immunostaining. three clones of 
McF7 and four clones of Krc/Y expressed exogenous 
S18-2 at a high level. For the further study, clone 1 of 
McF7 and clone 2 of Krc/Y were selected (Fig. 2A and 
Fig. 3. MCF7 and KRC/Y cell cultures, expressing ex-
ogenous S18-2 constitutively, show a high proportion of 
multinucleated cells. Dark-color bars represent the per-
centage of mitotic cells and light-color bars, percentage 
of multinucleated cells in the culture 
dark color – mitotic
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Fig. 2. A constitutive expression of S18-2 protein in the MCF7 and KRC/Y cells as compared to vector-transfected 
cells. The membrane was probed with anti-S18-2 rabbit serum and mouse anti-actin antibodies. Secondary antibodies 
(sheep anti-rabbit and anti-mouse horse radish peroxidase conjugated, GE-Healthcare, Uppsala, Sweden) and En-
hanced chemiluminescence kit (GE-Healthcare) were used to monitor protein bands. a, transfection of MCF7 cells with 
MT-S18-2 plasmid; B, transfection of KRC/Y cells with GFP-∆LANA-S18-2 plasmid. Note the expression of endogenous 
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Fig. 4. Multinucleated 
cells in the MCF7 cell 
culture expressing 
S18-2 constitutively. 
The percentage of 
multinucleated cells 
is shown in panels 
a and b (20×). At 
higher magnification 
(63×), large single 
nucleoli in multinucle-
ated cells can be seen 
(panels c–f). Signal 
of MT-S18-2 fusion 
protein stained with 
anti-c-myc antibody is 
shown in green; DNA 







B). noteworthy, the endogenous S18-2 was expressed 
at low levels in both cell lines. 
MT-S18-2 overexpression leads to the 
appearance of multinucleated cells
McF7-clone 1 and Krc/Y-clone 2 cells that expressed 
S18-2 constitutively, along with vector-transfected 
cells, were passaged for more than 20 population dou-
blings. We have observed an extremely high frequency 
of multinucleated cells (Fig. 3). Approximately 12% of 
McF7 cells and 15% of Krc/Y cells that expressed ex-
ogenous S18-2 protein at a high level, were multinucle-
ated. Such cells were observed after sequential freezing 
and thawing of the culture. noteworthy, the nucleoli in 
multinucleated cells were enlarged (Fig. 4, panels c, e, 
and f), suggesting an enhanced protein synthesis. 
In order to investigate a possible mechanism of 
multinucleated cell formation, we analyzed the cell cy-
cle distribution in 18IM cells. the percentage of cells 
in S-phase was much higher in 18IM cells than that 
in reFs (Fig. 5). A corresponding reduction in the cell 
number in G1-phase was also observed. A smaller 
number of cells in G
2
/M phase in 18IM cell culture may 
suggest that S18-2 protein, when expressed at a high 
level, leads to elevated transcription/translation, caus-
ing impaired mitosis. 
How the mitochondrial ribosomal protein S18-2 
can influence cell cycle regulation? Actually, it is well 
known that a crucial role in the G
1
/S checkpoint con-
trol is performed by retinoblastoma protein (rB) [9]. 
A hypo-phosphorylated form of rB binds to e2F1-5 
transcription factors and prevents the S-phase entry. 
Hyper-phosphorylation of rB results in freeing of 
e2F1-5 and activation of the e2F-dependent transcrip-
tion. As we mentioned earlier, we have found that S18-























Fig. 5. Cell cycle distribution in 18IM cells and control pri-
mary fibroblasts (REFs). The percentage of cells in S-phase 
is clearly elevated in 18IM cells, suggesting the deregula-
tion of cell cycle upon the S18-2 overexpression
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complexes with rB, inducing the S-phase [6, 7]. It may 
explain the increased number of cells in S-phase (Fig. 5) 
and, eventually, the formation of multinucleated cells. 
there could be other mechanisms leading to a 
creation of cells with more than one nucleus. For ex-
ample, enhanced expression of nucleoporin (nup153, 
nP_005115) led to the appearance of multinucleated 
HeLa cells, due to its binding to the MAD1 protein 
controlling mitotic spindle-assembly checkpoint [10]. 
Another example of similar action is overexpression 
of BcSG1 protein (gamma-synuclein, nP_003078) in 
breast cancer cell lines, leading to inactivation of Bubr1 
regulating mitotic checkpoint [11]. can S18-2 influence 
the cell division due to its binding to proteins control-
ling a mitotic pole formation? this question has no an-
swer yet, however. there are more than 70 mitochon-
drial ribosomal proteins encoded by the human genome 
(for review see [12]), and their functions are largely un-
known. Some studies suggested multiple functions of 
ribosomal proteins in mammalian cells. It was shown, 
for example, that MrPS29, one of the proteins of the 
small mitochondrial ribosome subunit, is not only in-
volved in the ribosome assembly but can also induce 
apoptosis [13, 14]. the mitochondrial ribosomal protein 
of large subunit, L41 (MrPL41), can induce G1 arrest 
[15, 16]. to further explore the functions of S18-2, we 
are currently looking for S18-2 binding proteins.
CONCLUSIONS
We have shown that overexpression of the mitochon-
drial ribosomal protein S18-2 in the human cancer cell 
lines McF7 and Krc/Y results in the appearance of 
multinucleated cells. this can be due to enhanced tran-
scription/translation and, probably, impaired mitosis. 
Further studies should be performed to analyze this 
phenomenon. 
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